These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 21919611

  • 21. Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71.
    Wang X, Dong K, Long M, Lin F, Gao Z, Wang L, Zhang Z, Chen X, Dai Y, Wang H, Zhang H.
    Arch Virol; 2018 Jul; 163(7):1851-1861. PubMed ID: 29582164
    [Abstract] [Full Text] [Related]

  • 22. Assembly and immunological properties of a bivalent virus-like particle (VLP) for avian influenza and Newcastle disease.
    Shen H, Xue C, Lv L, Wang W, Liu Q, Liu K, Chen X, Zheng J, Li X, Cao Y.
    Virus Res; 2013 Dec 26; 178(2):430-6. PubMed ID: 24050994
    [Abstract] [Full Text] [Related]

  • 23. Prevailing Sydney like Norovirus GII.4 VLPs induce systemic and mucosal immune responses in mice.
    Huo Y, Wan X, Ling T, Wu J, Wang Z, Meng S, Shen S.
    Mol Immunol; 2015 Dec 26; 68(2 Pt A):367-72. PubMed ID: 26375574
    [Abstract] [Full Text] [Related]

  • 24. DNA-MVA-protein vaccination of rhesus macaques induces HIV-specific immunity in mucosal-associated lymph nodes and functional antibodies.
    Chege GK, Burgers WA, Müller TL, Gray CM, Shephard EG, Barnett SW, Ferrari G, Montefiori D, Williamson C, Williamson AL.
    Vaccine; 2017 Feb 07; 35(6):929-937. PubMed ID: 28069361
    [Abstract] [Full Text] [Related]

  • 25. Translating antibody insights.
    Gerberding JL.
    Science; 2013 Sep 13; 341(6151):1151. PubMed ID: 24030986
    [No Abstract] [Full Text] [Related]

  • 26. Influence of routes and administration parameters on antibody response of pigs following DNA vaccination.
    Barfoed AM, Kristensen B, Dannemann-Jensen T, Viuff B, Bøtner A, Kamstrup S, Blixenkrone Møller M.
    Vaccine; 2004 Mar 29; 22(11-12):1395-405. PubMed ID: 15063562
    [Abstract] [Full Text] [Related]

  • 27. B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine.
    Ramani S, Neill FH, Ferreira J, Treanor JJ, Frey SE, Topham DJ, Goodwin RR, Borkowski A, Baehner F, Mendelman PM, Estes MK, Atmar RL.
    Clin Vaccine Immunol; 2017 May 29; 24(5):. PubMed ID: 28249841
    [Abstract] [Full Text] [Related]

  • 28. Protective effect of enterovirus‑71 (EV71) virus‑like particle vaccine against lethal EV71 infection in a neonatal mouse model.
    Cao L, Mao F, Pang Z, Yi Y, Qiu F, Tian R, Meng Q, Jia Z, Bi S.
    Mol Med Rep; 2015 Aug 29; 12(2):2473-80. PubMed ID: 25936344
    [Abstract] [Full Text] [Related]

  • 29. Efficient self-assembly and protective efficacy of infectious bursal disease virus-like particles by a recombinant baculovirus co-expressing precursor polyprotein and VP4.
    Lee HJ, Kim JY, Kye SJ, Seul HJ, Jung SC, Choi KS.
    Virol J; 2015 Oct 26; 12():177. PubMed ID: 26502988
    [Abstract] [Full Text] [Related]

  • 30. MERS-CoV spike nanoparticles protect mice from MERS-CoV infection.
    Coleman CM, Venkataraman T, Liu YV, Glenn GM, Smith GE, Flyer DC, Frieman MB.
    Vaccine; 2017 Mar 14; 35(12):1586-1589. PubMed ID: 28237499
    [Abstract] [Full Text] [Related]

  • 31. Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein.
    Martins K, Carra JH, Cooper CL, Kwilas SA, Robinson CG, Shurtleff AC, Schokman RD, Kuehl KA, Wells JB, Steffens JT, van Tongeren SA, Hooper JW, Bavari S.
    Viral Immunol; 2015 Feb 14; 28(1):62-70. PubMed ID: 25514232
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Current status and future directions of fish vaccines employing virus-like particles.
    Jeong KH, Kim HJ, Kim HJ.
    Fish Shellfish Immunol; 2020 May 14; 100():49-57. PubMed ID: 32130976
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Efficacy of an autophagy-targeted DNA vaccine against avian leukosis virus subgroup J.
    Dai Z, Huang J, Lei X, Yan Y, Lu P, Zhang H, Lin W, Chen W, Ma J, Xie Q.
    Vaccine; 2017 Feb 01; 35(5):808-813. PubMed ID: 28049588
    [Abstract] [Full Text] [Related]

  • 39. Serological Responses to a Norovirus Nonstructural Fusion Protein after Vaccination and Infection.
    Hesse S, Neill FH, Estes MK, Shanker S, Prasad BV, Ferreira J, Atmar RL.
    Clin Vaccine Immunol; 2016 Feb 01; 23(2):181-3. PubMed ID: 26656120
    [Abstract] [Full Text] [Related]

  • 40. Chimpanzees as an animal model for human norovirus infection and vaccine development.
    Bok K, Parra GI, Mitra T, Abente E, Shaver CK, Boon D, Engle R, Yu C, Kapikian AZ, Sosnovtsev SV, Purcell RH, Green KY.
    Proc Natl Acad Sci U S A; 2011 Jan 04; 108(1):325-30. PubMed ID: 21173246
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.